PERSPECTA

News from every angle

Back to headlines

GSK Launches Tender Offer to Acquire Nuvalent Inc. for $124 Per Share

GSK plc (GSK) has initiated a tender offer to acquire Nuvalent Inc. at a price of $124 per share, signaling a significant move in the pharmaceutical industry.

30 Jun, 13:10 — 30 Jun, 13:10
PostShare

Sources

Showing 1 of 1 sources